Hasil Pencarian - Erkko Ylösmäki

  • Menampilkan 1 - 12 hasil dari 12
Perbaiki Hasil
  1. 1
    MicroRNA-mediated suppression of oncolytic adenovirus replication in human liver.

    MicroRNA-mediated suppression of oncolytic adenovirus replication in human liver. oleh Erkko Ylösmäki, Sergio Lavilla-Alonso, Sari Jäämaa, Markus Vähä-Koskela, Taija af Hällström, Akseli Hemminki, Johanna Arola, Heikki Mäkisalo, Kalle Saksela

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    A novel cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella

    A novel cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella oleh Manlio Fusciello, Erkko Ylösmäki, Sara Feola, Arttu Uoti, Beatriz Martins, Karri Aalto, Firas Hamdan, Jacopo Chiaro, Salvatore Russo, Tapani Viitala, Vincenzo Cerullo

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses

    GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses oleh Firas Hamdan, Beatriz Martins, Michaela Feodoroff, Yvonne Giannoula, Sara Feola, Manlio Fusciello, Jacopo Chiaro, Gabriella Antignani, Mikaela Grönholm, Erkko Ylösmäki, Vincenzo Cerullo

    Diterbitkan 2021-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy.

    Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy. oleh Leena Ylösmäki, Beatrice Polini, Sara Carpi, Beatriz Martins, Elena Smertina, Sara Feola, Manlio Fusciello, Karita Peltonen, Paola Nieri, Erkko Ylösmäki, Vincenzo Cerullo

    Diterbitkan 2019-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin

    Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin oleh Sara Feola, Manlio Fusciello, Beatriz Martins, Erkko Ylösmäki, Vincenzo Cerullo, Tapani Viitala, Firas Hamdan, Jacopo Chiaro, Leena Ylösmäki, Matthew J Vaughan, Prasad S Kulkarni

    Diterbitkan 2021-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    ANKRD54 preferentially selects Bruton's Tyrosine Kinase (BTK) from a Human Src-Homology 3 (SH3) domain library.

    ANKRD54 preferentially selects Bruton's Tyrosine Kinase (BTK) from a Human Src-Homology 3 (SH3) domain library. oleh Manuela O Gustafsson, Dara K Mohammad, Erkko Ylösmäki, Hyunseok Choi, Subhash Shrestha, Qing Wang, Beston F Nore, Kalle Saksela, C I Edvard Smith

    Diterbitkan 2017-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Controlled release of enhanced cross-hybrid IgGA Fc PD-L1 inhibitors using oncolytic adenoviruses

    Controlled release of enhanced cross-hybrid IgGA Fc PD-L1 inhibitors using oncolytic adenoviruses oleh Firas Hamdan, Michaela Feodoroff, Salvatore Russo, Manlio Fusciello, Sara Feola, Jacopo Chiaro, Gabriella Antignani, Francesca Greco, Jeanette Leusen, Erkko Ylösmäki, Mikaela Grönholm, Vincenzo Cerullo

    Diterbitkan 2023-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Peptides-Coated Oncolytic Vaccines for Cancer Personalized Medicine

    Peptides-Coated Oncolytic Vaccines for Cancer Personalized Medicine oleh Sara Feola, Sara Feola, Sara Feola, Sara Feola, Salvatore Russo, Salvatore Russo, Salvatore Russo, Salvatore Russo, Beatriz Martins, Beatriz Martins, Beatriz Martins, Beatriz Martins, Alessandra Lopes, Gaëlle Vandermeulen, Vinciane Fluhler, Vinciane Fluhler, Vinciane Fluhler, Vinciane Fluhler, Camilla De Giorgi, Camilla De Giorgi, Camilla De Giorgi, Camilla De Giorgi, Manlio Fusciello, Manlio Fusciello, Manlio Fusciello, Manlio Fusciello, Sari Pesonen, Erkko Ylösmäki, Erkko Ylösmäki, Erkko Ylösmäki, Erkko Ylösmäki, Gabriella Antignani, Gabriella Antignani, Gabriella Antignani, Gabriella Antignani, Jacopo Chiaro, Jacopo Chiaro, Jacopo Chiaro, Jacopo Chiaro, Firas Hamdan, Firas Hamdan, Firas Hamdan, Firas Hamdan, Michaela Feodoroff, Michaela Feodoroff, Michaela Feodoroff, Michaela Feodoroff, Mikaela Grönholm, Mikaela Grönholm, Mikaela Grönholm, Mikaela Grönholm, Vincenzo Cerullo, Vincenzo Cerullo, Vincenzo Cerullo, Vincenzo Cerullo, Vincenzo Cerullo

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform

    Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform oleh Erkko Ylösmäki, Leena Ylösmäki, Manlio Fusciello, Beatriz Martins, Petra Ahokas, Hanne Cojoc, Arttu Uoti, Sara Feola, Anna Kreutzman, Tuuli Ranki, Julia Karbach, Tapani Viitala, Petri Priha, Elke Jäger, Sari Pesonen, Vincenzo Cerullo

    Diterbitkan 2021-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines

    A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines oleh Sara Feola, Jacopo Chiaro, Beatriz Martins, Salvatore Russo, Manlio Fusciello, Erkko Ylösmäki, Chiara Bonini, Eliana Ruggiero, Firas Hamdan, Michaela Feodoroff, Gabriella Antignani, Tapani Viitala, Sari Pesonen, Mikaela Grönholm, Rui MM Branca, Janne Lehtiö, Vincenzo Cerullo

    Diterbitkan 2022-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Artificially cloaked viral nanovaccine for cancer immunotherapy

    Artificially cloaked viral nanovaccine for cancer immunotherapy oleh Manlio Fusciello, Flavia Fontana, Siri Tähtinen, Cristian Capasso, Sara Feola, Beatriz Martins, Jacopo Chiaro, Karita Peltonen, Leena Ylösmäki, Erkko Ylösmäki, Firas Hamdan, Otto K. Kari, Joseph Ndika, Harri Alenius, Arto Urtti, Jouni T. Hirvonen, Hélder A. Santos, Vincenzo Cerullo

    Diterbitkan 2019-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids

    Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vi... oleh Sara Feola, Manlio Fusciello, Beatriz Martins, Erkko Ylösmäki, Vincenzo Cerullo, Firas Hamdan, Jacopo Chiaro, Yvonne Giannoula, Maeve Long, Michaela Feodoroff, Gabriella Antignani, Salvatore Russo, Otto Kari, Petrus Järvinen, Harry Nisen, Anna Kreutzman, Satu Mustjoki, Thomas G McWilliams, Mikaela Grönholm, Moon Hee Lee

    Diterbitkan 2021-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: